CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Curis, Inc.
Curis, Inc.
AstraZeneca
Center for International Blood and Marrow Transplant Research
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
UNC Lineberger Comprehensive Cancer Center
Zhejiang DTRM Biopharma
Celgene
AO GENERIUM
Celgene
Takeda
AbbVie
University of California, San Francisco
Amgen Research (Munich) GmbH
LEO Pharma
Nordic Nanovector
University of North Carolina, Chapel Hill
Amgen Research (Munich) GmbH
Amgen Research (Munich) GmbH
Amgen Research (Munich) GmbH
Seagen Inc.
Ariad Pharmaceuticals
Antisoma Research